Search - tctmd.com

Displaying 341 - 360 of 411

Sort: Relevancy | Date

Presentation TCT 2014

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Ted E. Feldman

September 15, 2014

Presentation TCT 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog

September 15, 2014

Presentation TCT 2014

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Presenter: Matthew J. Price, Shephal Doshi

September 15, 2014

Presentation TCT 2014

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

Presenter: Matthew J. Price

September 15, 2014

Presentation TCT 2014

The Triple Therapy Conundrum: Treatment of the PCI Patient with Atrial Fibrillation

Presenter: Matthew J. Price, C. Michael Gibson

September 15, 2014

Presentation TCT 2014

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Presenter: Matthew J. Price, Michael D. Ezekowitz

September 15, 2014

Presentation TCT 2014

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Presentation TCT 2014

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

Presenter: Hilary Nierenberg, Julie Logan, Asma Hussaini

September 14, 2014

Presentation TCT 2014

The Electrophysiologists Approach to Managing Atrial Fibrillation

Presenter: Hilary Nierenberg, Julie Logan, Taya V. Glotzer

September 14, 2014

Presentation TCT 2014

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Matthew J. Price

September 13, 2014

Presentation LAA 2014

Atrial Fibrillation in Patient with Low Bleeding Risk

Presenter: John D. Carroll

July 19, 2014

Presentation LAA 2014

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Presenter: Matthew J. Price

July 19, 2014

Presentation LAA 2014

Quantifying stroke and bleeding risk in atrial fibrillation

Presenter: Stefan Bertog

July 17, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation Fellows 2014

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: William Gray

April 14, 2014

Presentation ECHO 2014

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Presenter: James D. Thomas

April 11, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

Advertisement

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

The Triple Therapy Conundrum: Treatment of the PCI Patient with Atrial Fibrillation

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Can LAA Closure Become the New Standard for Stroke Prevention?

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

The Electrophysiologists Approach to Managing Atrial Fibrillation

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Atrial Fibrillation in Patient with Low Bleeding Risk

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Quantifying stroke and bleeding risk in atrial fibrillation

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

LAA Closure for Nonvalvular Atrial Fibrillation

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content